JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on October 19, 2007
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/42/31060    most recent
M701639200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abad, M.
Right arrow Articles by Palmero, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abad, M.
Right arrow Articles by Palmero, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print August 10, 2007
J. Biol. Chem, 10.1074/jbc.M701639200
Submitted on February 23, 2007
Revised on August 6, 2007
Accepted on August 10, 2007

Ing1 mediates p53 accumulation and chromatin modification in response to oncogenic stress

Maria Abad, Camino Menendez, Annette Fuchtbauer, Manuel Serrano, Ernst-Martin Fuchtbauer, and Ignacio Palmero

Dpt. of Cancer Biology, Institute for Biomedical Research, CSIC, Madrid, Madrid E-28029

Corresponding Author: ipalmero{at}iib.uam.es

ING proteins are putative tumour suppressor proteins linked to the p53 pathway and to the chromatin modification machinery. Here, we have analysed the role of the products of the murine Ing1 locus in cellular tumour-protective responses, using mouse primary fibroblasts where the Ing1 locus has been inactivated by the integration of a ßgeo cassette. We show that Ing1-deficient MEFs display a defective senescence-like antiproliferative response against oncogenic Ras, affecting several senescence-specific markers. This phenotype is accompanied by a reduced accumulation of p53, which can be explained by the reduced basal p53 protein stability in the Ing1-deficient background. Ing1 deficiency also results in defects in the appearance of heterochromatic marks upon expression of oncogenic Ras, suggestive of impaired heterochromatin formation during oncogene-induced senescence. Our results support an important role for the Ing1 locus in protection against oncogenic stress in vivo, both as a mediator of p53 activation, and as a regulator of chromatin remodelling processes.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.